|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01419 HUMAN HEALTH
Nominal 
0.750 -0.010 (-1.316%) | 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 315,788 | 6.978% | 590,819 | 1,001,746 | 1,121,793 | 654,712 |
| Cost of Sales | (167,070) | 8.007% | (320,968) | (408,510) | (462,108) | (278,023) |
| Gross Profit | 148,718 | 5.845% | 269,851 | 593,236 | 659,685 | 376,689 |
| 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (179) | -76.447% | (1,271) | (1,543) | (1,977) | 990 | |
| Profit / (Loss) before Taxation | 20,066 | -16.161% | 26,564 | 238,816 | 445,262 | 168,820 | |
| Taxation | (3,244) | -16.842% | (2,375) | (57,977) | (69,953) | (24,367) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 16,822 | -16.029% | 24,189 | 180,839 | 375,309 | 144,453 | |
| 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | (4,754) | 9.615% | (8,932) | (194) | 2,735 | 2,639 |
| Depreciation & Amortisation | 32,829 | -0.867% | 68,009 | 74,790 | 63,074 | 67,598 |
| Directors' Emoluments | -- | -- | 13,214 | 19,253 | 13,049 | 9,738 |
| 2024/12 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 4.400 | -16.981% | 6.400 | 47.600 | 98.900 | 38.100 |
| DPS (cts) | 0.000 | -- | 2.800 | 16.000 | 30.000 | 12.000 |
| Dividend Payout Ratio (%) | -- | -- | 43.750% | 33.613% | 30.334% | 31.496% |
| Cash flow per share ($) | -- | -- | 0.035 | 1.750 | 0.779 | 0.225 |
| NBV per share ($) | 2.032 | -- | 2.020 | 2.129 | 1.955 | 1.081 |
| Remarks: | Real time quote last updated: 04/03/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 16,822,000 |
| %Change | -16.029% |
| EPS / (LPS) | HKD 0.044 |
| NBV Per Share ($) | HKD 2.032 |